News|Articles|April 30, 2026
Recap: Day 3 of Asembia AXS26
These discussions focused on gaps in artificial intelligence, community-based advanced therapy, and demands of federal drug price negotiations.
Advertisement
Advertisement
The Asembia AXS26 Summit sessions further emphasized the critical need for operational readiness across the specialty pharmacy ecosystem. As the industry grapples with the transition from theoretical innovation to large-scale implementation, these discussions focused on bridging the gaps in artificial intelligence (AI) production, community-based advanced therapy delivery, and the rigorous demands of federal drug price negotiations.
Advertisement
Advertisement
